Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery

Recruiting now

Conditions studied: Surgical Site Infection

In brief

The aim of the study is to elucidate, if the colonization of bacteria is lower on the Novosyn® CHD suture compared to uncoated Polyglactin 910 suture, which will be assessed by the incidence of surgical site infections (SSI: A1 and A2). The results of this registry will generate further clinical evidence for the use and the benefit of a Chlorhexidine coated suture used to close the wound after an emergency or elective laparoscopic or laparotomy surgery. The benefit for individual patients lies in the early diagnosis of complications and in the optimized postoperative controls of a clinical study.

Key facts

Study ID

NCT05966961

Run by

Aesculap AG

People needed

2998

Starts

2023-09-18

Expected to finish

2028-12-01

Last updated by the study team

2026-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing an emergency or elective laparotomy or laparoscopic surgery.
• Written informed consent
• Age≥ 18 years
• Not incapacitated patient

You may not qualify if…

• No exclusion criteria except patients with allergy or hypersensitivity to chlorhexidine

Where it is running

• Pineta Grande Hospital — Naples, Italy (enrolling)
• Hospital Clínico San Carlos — Madrid, Spain (enrolling)
• Hospital Universitario de Canarias — Santa Cruz de Tenerife, Spain (enrolling)
• Hospital Universitario Virgen del Rocío — Seville, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.